Prof. dr. Jan-Willem M. Beenakker

Professor in ophthalmic physics
Leiden University Medical Center
Depts. of Ophthalmology, Radiology and Radiation Oncology
Website: mreye.nl
E-mail: jwb@mreye.nl

Addresses

Visiting address:
Leiden University Medical Center
C.J. Gorter MRI Center (route 526)
Albinusdreef 2A
Leiden, The Netherlands

Mailing address:
Leiden University Medical Center
t.a.v. Prof. dr. J.W.M. Beenakker
postzone: J3-S
Postbus 9600
2300RC Leiden, The Netherlands

Born in Leiden (1984),
married and father of four children

Mission statement

I am an experimental physicist working at the interface of imaging technology and clinical care, translating innovations into the hospital setting. I design, build, and implement MRI-based solutions for ocular imaging, bringing them from concept to routine clinical use. By advancing non-invasive imaging for eye diseases, particularly uveal melanoma, I aim to improve treatment precision, preserve vision, and enhance patient outcomes.

My work focuses on MR-guided ocular treatments, quantitative imaging biomarkers of eye tumours, and the integration of optical and radiological imaging into a unified framework. Looking ahead, I aim to enable clipless, image-based ocular proton therapy, making treatment less invasive and better tailored to individual patient’s preferences.

I am committed to promoting open and collaborative science and to mentoring early-career researchers in both their scientific development and their growth as responsible and engaged academics.

Education and appointments

• 2026 - present, Full Professor, Leiden UMC, depts. of Ophthalmology, Radiology and Radiation Oncology
• 2025 - present, Principal Investigator, HollandPTC
• 2015 - 2026, Principal Investigator, Leiden UMC, depts. of Ophthalmology, Radiology and Radiation Oncology
• 2008 - 2012, PhD in Physics, Leiden Institute of Physics
  Title: Unravelling the collagen network of the arterial wall
  Promotor: Prof. dr. ir. T. H. Oosterkamp

Distinctions

• 2026: Appointed full professor in Ophthalmic physics at the Leiden University
• 2024: One of the three LUMC PhD Supervisors of the year
• 2022: Dutch Research Council (NWO) VIDI laureate
• 2021: C.J. Kok Prize for translational research on ocular MRI
• 2016: ESCRS clinical Research Award
• 2016: Best oncology MR-research award, ISMRM Singapore

Professional activities

Responsibilities

• 2025 - present: Board member of the LUMC NeuroScience research theme
• 2024 - present: Member of the scientific board of the HollandPTC
• 2024 - present: Member of the science committee of the Dutch Ophthalmologist’s Association (NOG)
• 2021 - 2026: Chair of Pathology and Oncology section of the European Vision and Eye Research Association (EVER)
• 2021 - present: Member of the Ocular Proton Therapy Committee of the PTCOG
• 2021 - 2026: Board member of European Vision and Eye Research Association (EVER)
• 2021, 2025: Jury member of NWO TTW Open Technology Program
• 2017 - present: Grant reviewer for various national and international organizations

Graduated PhD students

• L. Klaassen: Image-based ocular proton therapy, 2026
• L. van Vught: Uncovering the origin of negative dysphotopsia, 2025
• K. R. Keene: Function and structure of the eye muscles in myasthenia gravis, 2023
• T. A. Gonçalves-Ferreira: MR Imaging of Uveal Melanoma and Orbit, 2023
• M. G. Jaarsma-Coes, MRI for planning and characterization of uveal melanoma patients treated with proton beam therapy, 2023
• G. A. van Rijn: Safety of the artisan iris-fixated phakic intraocular lens, 2022
• Z. S. Gaurisankar: Phakic intraocular lens implantation: a life-long patient journey, 2022
• List of current group members
• PhD family tree (interactive overview of my academic lineage)

Conference activities

• 2025: Organizer of the “Physics in state-of-the-art imaging” symposium at NWO Physics
• 2024: Co-organizer of the 2nd international symposium on Ocular Proton Therapy
• 2023: Chair of the ocular oncology session at the Asia Pacific Academy of Ophthalmology conference in Kuala Lumpur
• 2023: Chair of the Oncology and Pathology session at the 2023 EVER congress in Valencia
• 2023: Organizer of a Negative Dysphotopsia symposium at the 2023 EVER congress in Valencia
• 2022 and 2023: Chair of the oncology and pathology sessions of the European Vision and Eye Research conference in Valencia
• 2021: Co-organizer and imaging session chair of first international ocular proton therapy course
• 2020: Coordinator and co-chair of European Vision Institute symposium on “New technologies for outcome measures in uveal melanoma” (Basel)
• 2015: Chair the scientific session on MR hardware development at the 7th annual ISMRM Benelux in Gent (Belgium)

Personal activities

• Since 2005 various responsibilities in national and international committees of the Emmanuel Community, a Catholic association with over 12.000 members in 72 countries. I’m currently part of the Dutch national governance and a member of the international advisory council (since 2018, re-elected in 2021 and 2026).
  Two examples of responsibilities that shaped my leadership and mentoring skills

  • I've set-up the Dutch version of the Zacchaeus Course, a programme which helps the participants discover how to achieve unity and coherence in their lives, between their Christian faith and their day to day actions.
  • I have been in charge of the national youth team for 2008-2012. Together with my wife, I was a mentor for the youth, guided the local youth teams and (co-)organized over ten journeys in- and outside of Europe (impression). After our service in the youth team, we were responsible for the community in the West of the Netherlands (until 2020).
• Since 2015 a board member of the Dutch chapter of Aid to the Church in Need, a charity with approximately 4-6 million Euro of donations annually.

Publications

Open Science

• Visisipy is a Python library for optical simulations of the eye (2025 - present)
  https://github.com/MREYE-LUMC/visisipy
  Role: Main author, active maintainer
• ZOSPy, an API for OpticStudio enabling automatic analyses (2021 - present)
  https://github.com/MREYE-LUMC/ZOSPy
  Role: Main author, active maintainer
• Various eye-models and associated ray-tracing analyses (2021 - present)
  https://github.com/MREYE-LUMC/ZOSPy/tree/main/examples/
  Role: main author
• T2EPG, EGP-based T2 analysis for muscle MRI (2022)
  https://git.lumc.nl/neuroscience/multicomponent_t2_epg
  Role: Contributor
• VFPy, a digitizing toolbox for Humphrey Visual Field analyses (2021)
  https://github.com/MREYE-LUMC/VFPy
  Role: Main author
• Ocular MRI protocol (2021)
  https://www.mriclinicalcasemap.philips.com/global/case/264
  Role: Main author
• PyZDDE, a Python link to Zemax API (2018)
  https://github.com/xzos/PyZDDE
  Role: Contributor

General public

• 2025: Interview for the Patient’s Association Oogfonds on a new project to develop an ocular cone-beam CT

• 2024: Article in the Dutch Physics Magazine (NTVN) on the physics of developing ocular MRI

• 2024: Article/interview in Medisch Contact: “PAROS: innovatieve methode voor het corrigeren van oogfoto's”

• 2024: Interview in Resultaat, the annual magazine of the Dutch Research Council [Dutch]/[English]

• 2023: Lecture on MRI for uveal melanoma at the annual patient day of Stichting Melanoom

• 2022: Lecture on “Working as a physicist in a hospital” at the annual gathering of the Dutch physics high-school teachers.

• 2022: Educational lectures on the technical and clinical aspects MRI for ocular proton therapy

• 2020: Article on “MRI for uvea melanoma” in De Oogarts

• 2020: Podcast on Ocular MRI of the Oogvereniging

Invited lectures

• 2024: Imaging for ocular proton therapy; OCULAR symposium, Villigen (Switzerland)
• 2023: Optical Ray tracing for Negative Dysphotopsia; European Society for Vision and Eye Research; Valencia (Spain)
• 2023: MRI for ocular proton therapy; European Ocular Oncology Group; Berlin (Germany);
• 2023: MRI for ocular radiotherapy planning; Asia Pacific Ophthalmic Academy; Kuala Lumpur (Malaysia)
• 2022: MRI of the eye; Brighton university; Brighton (UK)
• 2022: Imaging in Uveal Melanoma; International Society for Ocular Oncology; Leiden
• 2022: How can MRI help to optimise the treatment for Uveal Melanoma; Bebig; Leiden
• 2022: Is MRI useful to diagnose intra-ocular tumours?; International Society for Ocular Oncology; Leiden
• 2022: MRI for ocular proton therapy planning; International Ocular Proton Therapy Committee; Online/Villigen (Switzerland)
• 2021: MRI for ocular oncology; Asia Pacific Vitreo-Retina Society; originally in Hong Kong but online due to COVID
• 2021: MRI for Uveal Melanoma; European Vision Institute; originally in Basel (Switzerland) but online due to COVID
• 2020: Development of MRI-based proton therapy planning, European Society Magnetic Resonance in Medicine and Biology; Barcelona (Spain)
• 2020: MRI for ophthalmic conditions; German ophthalmic society (DOG), Berlin (Germany)
• 2020: The role of MRI in the care for Uveal Melanoma, World of Ophthalmology; Cape Town (South Africa)
• 2020: Quantitative MRI for Ocular Oncology, World of Ophthalmology; Cape Town (South Africa)
• 2019: The vRESPOND study; European Society of Cataract and Refractive Surgeons Society; Paris (France)
• 2017: Clinical Evaluation of UHF MRI for Uveal Melanoma; Asia-Pacific Congress of Ophthalmology; Singapore
• 2015: High resolution imaging of the eye; Laboratoria de Optica; Murcia (Spain)
• 2015: Ocular MRI; International Society of Magnetic Resonance Imaging in Medicine; Toronto (Canada)

Scientific Publications

2026

1. PTCOG Ocular Survey - Perspective on Ocular Particle Therapy: Current Practices and Emerging Trends.

   Mortimer, Slopsema, Mazal, Beenakker, Dendale, Denker, Fleury, Groulier, Kacperek, Mishra, Saini, Trofimov, Thariat, Trnková, Vidal, Shih, Hrbacek and Heufelder
   International journal of particle therapy (2026), doi: 10.1016/j.ijpt.2026.101300 

2025

2. A Novel MRI-Based Approach to Peripheral Refraction and Prediction of Myopia Progression

   Kneepkens, Vught, Polling, Klaver, Tideman and Beenakker
   American Journal of Ophthalmology (2025), doi: 10.1016/j.ajo.2025.06.013 
3. Accuracy of day-to-day patient positioning in ocular proton therapy with a dedicated beamline

   Hol, Spruijt, Rodrigues, Klaver, Kouwenberg, Bakker, Luyten, Kiliç, Beenakker, Astreinidou and Rasch
   PLOS One (2025), doi: 10.1371/journal.pone.0333294 
4. Clinical outcomes and risk factors for local failure and visual impairment in patients treated with Ru-106 brachytherapy for uveal melanoma

   Pors, Marinkovic, Deuzeman, Vu, Kerkhof, Wieringen-Warmenhoven, Rasch, Bleeker, Koetsier, Beenakker, Luyten, Creutzberg and Horeweg
   Clinical and Translational Radiation Oncology (2025), doi: 10.1016/j.ctro.2025.100939 
5. Estimating uveal melanoma volume with ellipsoid tumour models

   Klaassen, Ferreira, Luyten and Beenakker
   Acta Ophthalmologica (2025), doi: 10.1111/aos.17492 
6. Evaluation of MRI Safety of Ru-106 Eye Applicators

   Tang, Klaassen, Marinkovic, Vu, Luyten, Creutzberg, Ketelaars and Beenakker
   Ocular Oncology and Pathology (2025), doi: 10.1159/000542712 
7. Patient‐specific mapping of fundus photographs to three‐dimensional ocular imaging

   Haasjes, Vu and Beenakker
   Medical Physics (2025), doi: 10.1002/mp.17576 

2024

8. Correction Method for Optical Scaling of Fundoscopy Images: Development, Validation, and First Implementation

   Pors, Haasjes, Vught, Hoes, Luyten, Rijn, Vu, Rasch, Horeweg and Beenakker
   Investigative Opthalmology & Visual Science (2024), doi: 10.1167/iovs.65.1.43 
9. Geometrical accuracy of magnetic resonance imaging for ocular proton therapy planning

   Klaassen, Haasjes, Hol, Lopes, Spruijt, Steeg-Henzen, Vu, Bakker, Rasch, Verbist and Beenakker
   Physics and Imaging in Radiation Oncology (2024), doi: 10.1016/j.phro.2024.100598 
10. Measuring quality of vision including negative dysphotopsia

    Makhotkina, Nijkamp, Berendschot, Borne, Kruchten, Vught, Beenakker, Krijgh, Aslam, Pesudovs and Nuijts
    Acta Ophthalmologica (2024), doi: 10.1111/aos.15762 
11. PTCOG Ocular Statement: Expert Summary of Current Practices and Future Developments in Ocular Proton Therapy

    Hrbacek, Kacperek, Beenakker, Mortimer, Denker, Mazal, Shih, Dendale, Slopsema, Heufelder and Mishra
    International Journal of Radiation Oncology*Biology*Physics (2024), doi: 10.1016/j.ijrobp.2024.06.017 
12. Quantitative Perfusion-Weighted Magnetic Resonance Imaging in Uveal Melanoma

    Klaassen, Jaarsma-Coes, Marinkovic, Luyten, Rasch, Ferreira and Beenakker
    Investigative Ophthalmology & Visual Science (2024), doi: 10.1167/iovs.65.11.17 
13. ZOSPy: optical ray tracing in Python through OpticStudio

    Vught, Haasjes and Beenakker
    Journal of Open Source Software (2024), doi: 10.21105/joss.05756 

2023

14. Comparison of Magnetic Resonance Imaging–Based and Conventional Measurements for Proton Beam Therapy of Uveal Melanoma

    Jaarsma-Coes, Ferreira, Marinkovic, Vu, Vught, Haren, Rodrigues, Klaver, Verbist, Luyten, Rasch and Beenakker
    Ophthalmology Retina (2023), doi: 10.1016/j.oret.2022.06.019 
15. Diagnosing myasthenia gravis using orthoptic measurements: assessing extraocular muscle fatiguability

    Keene, Nie, Brink, Notting, Verschuuren, Kan, Beenakker and Tannemaat
    Journal of Neurology, Neurosurgery & Psychiatry (2023), doi: 10.1136/jnnp-2022-329859 
16. Eye Muscle MRI in Myasthenia Gravis and Other Neuromuscular Disorders

    Keene, Notting, Verschuuren, Voermans, Keizer, Beenakker, Tannemaat and Kan
    Journal of Neuromuscular Diseases (2023), doi: 10.3233/jnd-230023 
17. Inter-Observer Variability in MR-Based Target Volume Delineation of Uveal Melanoma

    Jaarsma-Coes, Klaassen, Verbist, Vu, Klaver, Rodrigues, Nabarro, Luyten, Rasch, Herk and Beenakker
    Advances in Radiation Oncology (2023), doi: 10.1016/j.adro.2022.101149 
18. Magnetic Resonance Imaging in the Clinical Care for Uveal Melanoma Patients—A Systematic Review from an Ophthalmic Perspective

    Jaarsma-Coes, Klaassen, Marinkovic, Luyten, Vu, Ferreira and Beenakker
    Cancers (2023), doi: 10.3390/cancers15112995 
19. More on light dysphotopsia origin in pseudophakia

    Grzybowski and Beenakker
    Graefe's Archive for Clinical and Experimental Ophthalmology (2023), doi: 10.1007/s00417-023-06029-w 
20. MR-based follow-up after brachytherapy and proton beam therapy in uveal melanoma

    Tang, Ferreira, Marinkovic, Jaarsma-Coes, Klaassen, Vu, Creutzberg, Rodrigues, Horeweg, Klaver, Rasch, Luyten and Beenakker
    Neuroradiology (2023), doi: 10.1007/s00234-023-03166-1 
21. Peripheral visual field shifts after intraocular lens implantation

    Vught, Luyten and Beenakker
    Journal of Cataract & Refractive Surgery (2023), doi: 10.1097/j.jcrs.0000000000001299 
22. Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period

    Tong, Bastiaannet, Speetjens, Blank, Luyten, Jager, Marinkovic, Vu, Rasch, Creutzberg, Beenakker, Hartgrink, Bosch, Kiliç, Naus, Yavuzyigitoglu, Rij, Burgmans and Kapiteijn
    Cancers (2023), doi: 10.3390/cancers15225419 

2022

23. A Comparison of 3 T and 7 T MRI for the Clinical Evaluation of Uveal Melanoma

    Tang, Jaarsma‐Coes, Ferreira, Fonk, Marinkovic, Luyten and Beenakker
    Journal of Magnetic Resonance Imaging (2022), doi: 10.1002/jmri.27939 
24. Automatic Three-Dimensional Magnetic Resonance-based measurements of tumour prominence and basal diameter for treatment planning of uveal melanoma

    Klaassen, Jaarsma-Coes, Verbist, Vu, Marinkovic, Rasch, Luyten and Beenakker
    Physics and Imaging in Radiation Oncology (2022), doi: 10.1016/j.phro.2022.11.001 
25. Clinical and imaging clues to the diagnosis and follow‐up of ptosis and ophthalmoparesis

    Keene, Kan, Meeren, Verbist, Tannemaat, Beenakker and Verschuuren
    Journal of Cachexia, Sarcopenia and Muscle (2022), doi: 10.1002/jcsm.13089 
26. Effect of anatomical differences and intraocular lens design on negative dysphotopsia

    Vught, Que, Luyten and Beenakker
    Journal of Cataract & Refractive Surgery (2022), doi: 10.1097/j.jcrs.0000000000001054 
27. Eye-specific quantitative dynamic contrast-enhanced MRI analysis for patients with intraocular masses

    Jaarsma-Coes, Ferreira, Houdt, Heide, Luyten and Beenakker
    Magnetic Resonance Materials in Physics, Biology and Medicine (2022), doi: 10.1007/s10334-021-00961-w 
28. Letter to the Editor of Radiotherapy and Oncology regarding the paper titled “MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy” by Via et al.

    Beenakker and Rasch
    Radiotherapy and Oncology (2022), doi: 10.1016/j.radonc.2022.08.018 
29. Magnetic resonance imaging reveals possible cause of diplopia after Baerveldt glaucoma implantation

    Islamaj, Vught, Jordaan-Kuip, Vermeer, Ferreira, Waard, Lemij and Beenakker
    PLoS ONE (2022), doi: 10.1371/journal.pone.0276527 
30. MR imaging characteristics of uveal melanoma with histopathological validation

    Ferreira, Jaarsma-Coes, Marinkovic, Verbist, Verdijk, Jager, Luyten and Beenakker
    Neuroradiology (2022), doi: 10.1007/s00234-021-02825-5 
31. Outcome Measures of New Technologies in Uveal Melanoma: Review from the European Vision Institute Special Interest Focus Group Meeting

    Beenakker, Brouwer, Chau, Coupland, Fiorentzis, Heimann, Heufelder, Joussen, Kiilgaard, Kivelä, Piperno-Neumann, Rantala, Romanowska-Dixon, Shields, Willerding, Wheeler-Schilling, Scholl, Jager, Damato and Oncology, European Ocular Oncology Group and the International Society of Ocular
    Ophthalmic Research (2022), doi: 10.1159/000524372 
32. The Value of Static Perimetry in the Diagnosis and Follow-up of Negative Dysphotopsia

    Rozendal, Vught, Luyten and Beenakker
    Optometry and Vision Science (2022), doi: 10.1097/opx.0000000000001918 
33. Two-year results after combined phacoemulsification and iris-fixated phakic intraocular lens removal

    Gaurisankar, Rijn, Cheng, Luyten and Beenakker
    Graefe's Archive for Clinical and Experimental Ophthalmology (2022), doi: 10.1007/s00417-021-05442-3 

2021

34. An Automatic Framework to Create Patient-specific Eye Models From 3D Magnetic Resonance Images for Treatment Selection in Patients With Uveal Melanoma

    Hassan, Fleury, Shamonin, Fonk, Marinkovic, Jaarsma-Coes, Luyten, Webb, Beenakker and Stoel
    Advances in Radiation Oncology (2021), doi: 10.1016/j.adro.2021.100697 
35. Differences between Scheimpflug and optical coherence tomography in determining safety distances in eyes with an iris-fixating phakic intraocular lens

    Gaurisankar, Rijn, Luyten and Beenakker
    Graefe's Archive for Clinical and Experimental Ophthalmology (2021), doi: 10.1007/s00417-020-04874-7 
36. Evaluation of intraocular lens position and retinal shape in negative dysphotopsia using high-resolution magnetic resonance imaging

    Vught, Dekker, Stoel, Luyten and Beenakker
    Journal of Cataract & Refractive Surgery (2021), doi: 10.1097/j.jcrs.0000000000000576 
37. Implantation of an iris-fixated phakic intraocular lens for the correction of hyperopia: 15-year follow-up

    Rijn, Gaurisankar, Saxena, Gibbes, Jongman, Haasnoot, Cheng, Beenakker and Luyten
    Journal of Cataract & Refractive Surgery (2021), doi: 10.1097/j.jcrs.0000000000000532 
38. Long‐term longitudinal changes in axial length in the Caucasian myopic and hyperopic population with a phakic intraocular lens

    Gaurisankar, Rijn, Haasnoot, Verhoeven, Klaver, Luyten and Beenakker
    Acta Ophthalmologica (2021), doi: 10.1111/aos.14647 
39. MRI-based 3D retinal shape determination

    Vught, Shamonin, Luyten, Stoel and Beenakker
    BMJ Open Ophthalmology (2021), doi: 10.1136/bmjophth-2021-000855 
40. Ophthalmic Magnetic Resonance Imaging: Where Are We (Heading To)?

    Niendorf, Beenakker, Langner, Erb-Eigner, Cuadra, Beller, Millward, Niendorf and Stachs
    Current Eye Research (2021), doi: 10.1080/02713683.2021.1874021 
41. Reply to comment on: Distinct differences in anterior chamber configuration and peripheral aberrations in negative dysphotop

    Vught, Beenakker and Luyten
    Journal of Cataract & Refractive Surgery (2021), doi: 10.1097/j.jcrs.0000000000000431 
42. Selection Approach to Identify the Optimal Biomarker Using Quantitative Muscle MRI and Functional Assessments in Becker Muscular Dystrophy

    Velde, Hooijmans, Mishre, Keene, Koeks, Veeger, Alleman, Zwet, Beenakker, Verschuuren, Kan and Niks
    Neurology (2021), doi: 10.1212/wnl.0000000000012233 
43. The feasibility of quantitative MRI of extra‐ocular muscles in myasthenia gravis and Graves' orbitopathy

    Keene, Vught, Velde, Ciggaar, Notting, Genders, Verschuuren, Tannemaat, Kan and Beenakker
    NMR in Biomedicine (2021), doi: 10.1002/nbm.4407 
44. Three‐dimensional MRI‐based treatment planning approach for non‐invasive ocular proton therapy

    Fleury, Trnková, Erdal, Hassan, Stoel, Jaarma‐Coes, Luyten, Herault, Webb, Beenakker, Pignol and Hoogeman
    Medical Physics (2021), doi: 10.1002/mp.14665 

2020

45. Distinct differences in anterior chamber configuration and peripheral aberrations in negative dysphotopsia

    Vught, Luyten and Beenakker
    Journal of Cataract and Refractive Surgery (2020), doi: 10.1097/j.jcrs.0000000000000206 
46. Improved Interchangeability with Different Corneal Specular Microscopes for Quantitative Endothelial Cell Analysis

    Rijn, Wijnen, Dooren, Cheng, Beenakker and Luyten
    Clinical Ophthalmology (2020), doi: 10.2147/opth.s228347 
47. Measuring eye deformation between planning and proton beam therapy position using magnetic resonance imaging

    Jaarsma-Coes, Marinkovic, Astreinidou, Schuurmans, Peters, Luyten, Rasch and Beenakker
    Physics and Imaging in Radiation Oncology (2020), doi: 10.1016/j.phro.2020.09.010 
48. Middle- and long-term results after iris-fixated phakic intraocular lens implantation in myopic and hyperopic patients: a meta-analysis

    Rijn, Gaurisankar, Ilgenfritz, Lima, Haasnoot, Beenakker, Cheng and Luyten
    Journal of Cataract and Refractive Surgery (2020), doi: 10.1097/j.jcrs.0000000000000002 
49. MR and CT Imaging of the Normal Eyelid and its Application in Eyelid Tumors

    Ferreira, Pinheiro, Saraiva, Jaarsma-Coes, Duinen, Genders, Marinkovic and Beenakker
    Cancers (2020), doi: 10.3390/cancers12030658 
50. T2 relaxation‐time mapping in healthy and diseased skeletal muscle using extended phase graph algorithms

    Keene, Beenakker, Hooijmans, Naarding, Niks, Otto, Pol, Tannemaat, Kan and Froeling
    Magnetic Resonance in Medicine (2020), doi: 10.1002/mrm.28290 
51. The Economic Value of MR-Imaging for Uveal Melanoma

    Fonk, Ferreira, Webb, Luyten and Beenakker
    Clinical Ophthalmology (2020), doi: 10.2147/opth.s238405 

2019

52. Cartesian MR fingerprinting in the eye at 7T using compressed sensing and matrix completion‐based reconstructions

    Koolstra, Beenakker, Koken, Webb and Börnert
    Magnetic Resonance in Medicine (2019), doi: 10.1002/mrm.27594 
53. Correlations between ocular biometrics and refractive error: A systematic review and meta‐analysis

    Gaurisankar, Rijn, Lima, Ilgenfritz, Cheng, Haasnoot, Luyten and Beenakker
    Acta Ophthalmologica (2019), doi: 10.1111/aos.14208 
54. MRI enables accurate diagnosis and follow-up in uveal melanoma patients after vitrectomy

    Jaarsma-Coes, Ferreira, Haren, Marinkovic and Beenakker
    Melanoma Research (2019), doi: 10.1097/cmr.0000000000000568 
55. MRI of Uveal Melanoma

    Ferreira, Fonk, Jaarsma-Coes, Haren, Marinkovic and Beenakker
    Cancers (2019), doi: 10.3390/cancers11030377 
56. Reaction on “Ocular ultrasound versus MRI in the detection of extrascleral extension in a patient with choroidal melanoma”

    Jaarsma-Coes, Ferreira, Luyten and Beenakker
    BMC Ophthalmology (2019), doi: 10.1186/s12886-019-1206-y 
57. Silent volumetric multi-contrast 7 Tesla MRI of ocular tumors using Zero Echo Time imaging

    Beenakker, Wezel, Groen, Webb and Börnert
    PLoS ONE (2019), doi: 10.1371/journal.pone.0222573 

2018

58. 9.4T and 17.6T MRI of Retinoblastoma: Ex Vivo evaluation of microstructural anatomy and disease extent compared with histopathology

    Jong, Graaf, Pouwels, Beenakker, Jansen, Geurts, Moll, Castelijns, Valk and Weerd
    Journal of Magnetic Resonance Imaging (2018), doi: 10.1002/jmri.25913 
59. CT and MR imaging of orbital inflammation

    Ferreira, Saraiva, Genders, Buchem, Luyten and Beenakker
    Neuroradiology (2018), doi: 10.1007/s00234-018-2103-4 

2017

60. Automated eye blink detection and correction method for clinical MR eye imaging

    Wezel, Garpebring, Webb, Osch and Beenakker
    Magnetic Resonance in Medicine (2017), doi: 10.1002/mrm.26355 
61. Equilibrium shape of the aqueous humor-vitreous substitute interface in vitrectomized eyes

    Isakova, Pralits, Romano, Beenakker, Shamonin and Repetto
    Modeling and Artificial Intelligence in Ophthalmology (2017), doi: 10.35119/maio.v1i3.36 
62. Validation of a pharmacological model for mitochondrial dysfunction in healthy subjects using simvastatin: A randomized placebo-controlled proof-of-pharmacology study

    Diemen, Berends, Akram, Wezel, Teeuwisse, Mik, Kan, Webb, Beenakker and Groeneveld
    European Journal of Pharmacology (2017), doi: 10.1016/j.ejphar.2017.09.031 

2016

63. Clinical evaluation of ultra-high-field MRI for three-dimensional visualisation of tumour size in uveal melanoma patients, with direct relevance to treatment planning

    Beenakker, Ferreira, Soemarwoto, Genders, Teeuwisse, Webb and Luyten
    Magnetic Resonance Materials in Physics, Biology and Medicine (2016), doi: 10.1007/s10334-016-0529-4 

2015

64. Automated Retinal Topographic Maps Measured With Magnetic Resonance Imaging

    Beenakker, Shamonin, Webb, Luyten and Stoel
    Investigative Ophthalmology & Visual Science (2015), doi: 10.1167/iovs.14-15161 

2014

65. A multi-purpose open-source triggering platform for magnetic resonance

    Ruytenberg, Webb and Beenakker
    Journal of Magnetic Resonance (2014), doi: 10.1016/j.jmr.2014.08.009 

2013

66. Design and performance of a transformer‐coupled double resonant quadrature birdcage coil for localized proton and phosphorus spectroscopy in the human calf muscle at 7 T

    Brand, Webb and Beenakker
    Concepts in Magnetic Resonance Part A (2013), doi: 10.1002/cmr.a.21281
67. High‐resolution MRI of uveal melanoma using a microcoil phased array at 7 T

    Beenakker, Rijn, Luyten and Webb
    NMR in Biomedicine (2013), doi: 10.1002/nbm.3041 

2012

68. Mechanical Properties of the Extracellular Matrix of the Aorta Studied by Enzymatic Treatments

    Beenakker, Ashcroft, Lindeman and Oosterkamp
    Biophysical Journal (2012), doi: 10.1016/j.bpj.2012.03.041 
69. Neutrophil‐mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model

    He, Lamers, Beenakker, Cui, Ghotra, Danen, Meijer, Spaink and Snaar‐Jagalska
    The Journal of Pathology (2012), doi: 10.1002/path.4013 

2010

70. Distinct defects in collagen microarchitecture underlie vessel-wall failure in advanced abdominal aneurysms and aneurysms in Marfan syndrome

    Lindeman, Ashcroft, Beenakker, Es, Koekkoek, Prins, Tielemans, Abdul-Hussien, Bank and Oosterkamp
    Proceedings of the National Academy of Sciences (2010), doi: 10.1073/pnas.0910312107